US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 7.510
  • -0.160-2.09%
Close Feb 28 16:00 ET
  • 7.570
  • +0.060+0.80%
Post 19:59 ET
3.02BMarket Cap-4.44P/E (TTM)

Recursion Pharmaceuticals Key Stats

Recursion Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 28, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
19.04M
4.55M
-14.50M
Miss Est.
+74.85%
-58.26%
-76.13%
EPS
-0.46
-0.53
-0.07
Miss Est.
-8.76%
-26.19%
-16.05%
Buy

Feb 28, 2025

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 24.825M--
--2025/Q1-- / 24.833M--
Feb 28, 20252024/Q44.546M / 19.043M--
Nov 6, 20242024/Q326.082M / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 24.825M--
--2025/Q1-- / 24.833M--
Feb 28, 20252024/Q44.546M / 19.043M--
Nov 6, 20242024/Q326.082M / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--

Unlock Free Earnings Estimates

Recursion Pharmaceuticals Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Buy

  • Buy

    40.00%
  • Hold

    60.00%
  • Sell

    0.00%

Price Target

No Data